Missouri 2025 Regular Session

Missouri Senate Bill SB448 Latest Draft

Bill / Introduced Version Filed 12/06/2024

                             
FIRST REGULAR SESSION 
SENATE BILL NO. 448 
103RD GENERAL ASSEMBLY  
INTRODUCED BY SENATOR TRENT. 
0063S.01I 	KRISTINA MARTIN, Secretary  
AN ACT 
To amend chapter 537, RSMo, by adding thereto one new section relating to liability for disclosure 
of biometric information. 
 
Be it enacted by the General Assembly of the State of Missouri, as follows: 
     Section A.  Chapter 537, RSMo, is amended b y adding thereto 1 
one new section, to be known as section 537.323, to read as 2 
follows:3 
     537.323.  1.  As used in this section, the following 1 
terms mean: 2 
     (1)  "Biometric identifier", a retina or iris scan, 3 
fingerprint, voiceprint, or scan of hand or face geometry.   4 
The term "biometric identifier" shall not include the 5 
following: 6 
     (a)  Any writing sample, written signature, photograph, 7 
human biological sample used for valid scientific testing or 8 
screening, demographic data, tattoo descripti ons, or  9 
physical descriptions such as height, weight, hair color, or 10 
eye color; 11 
     (b)  Any anatomical gift, tissue, or part, as such 12 
terms are defined in section 194.210, or any blood or serum 13 
stored on behalf of recipients or potential recipients o f  14 
living or cadaveric transplants and obtained or stored by a 15 
federally designated organ procurement organization; 16 
     (c)  Biometric data used in genetic testing, including 17 
any direct-to-consumer genetic testing, as such term is 18 
defined in 45 CFR 160 .103; 19   SB 448 	2 
     (d)  Information captured from a patient in a health 20 
care setting or information collected, used, or stored for 21 
health care treatment, payment, or operations under the 22 
federal Health Insurance Portability and Accountability Act 23 
of 1996 (HIPAA), P.L. 104-191, as amended; or 24 
     (e)  Any X-ray, roentgen process, computed tomography, 25 
MRI, PET scan, mammography, or other image or film of the 26 
human anatomy used to diagnose, prognose, or treat an 27 
illness or other medical condition or to further validate  28 
scientific testing or screening; 29 
     (2)  "Biometric information", any information, 30 
regardless of how it is captured, converted, stored, or 31 
shared, based on an individual's biometric identifier used 32 
to identify an individual.  The term "biometric information" 33 
shall not include information derived from items or 34 
procedures provided in paragraphs (a) to (e) of subdivision 35 
(1) of this subsection; 36 
     (3)  "Confidential and sensitive information", personal 37 
information that can be used to uniq uely identify an  38 
individual or an individual's account or property.  The term  39 
"confidential and sensitive information" includes, but is 40 
not limited to, a genetic marker, genetic testing 41 
information, a unique identifier number to locate an account 42 
or property, an account number, a PIN number, a passcode, a 43 
driver's license number, or a Social Security number; 44 
     (4)  "Private entity", any individual, partnership, 45 
corporation, limited liability company, or association.  The  46 
term "private entity" sha ll not include a state or local 47 
government agency, or any employee or agent thereof, or a 48 
court of this state, or any clerk, judge, or justice thereof. 49 
     2.  Except as provided in subsection 4 of this section, 50 
a private entity in possession of biomet ric identifiers or 51   SB 448 	3 
biometric information shall not be liable for damages for 52 
the unauthorized or negligent disclosure of biometric 53 
identifiers or biometric information if the private entity: 54 
     (1)  Posts and maintains signs or notices which contain 55 
the warning as specified in subsection 3 of this section; 56 
     (2)  Informs the public and the individual whose 57 
biometric identifier or biometric information is being 58 
collected, captured, or otherwise obtained of the specific 59 
purpose for which the biome tric identifier or biometric 60 
information is being used; 61 
     (3)  Develops a written policy, made available to the 62 
public, establishing a retention schedule and guidelines for 63 
permanently destroying biometric identifiers and biometric 64 
information when the initial purpose for collecting or 65 
obtaining such biometric identifiers or biometric 66 
information has been satisfied or within three years of the 67 
individual's last interaction with the private entity, 68 
whichever occurs first; 69 
     (4)  Complies with the written policy described in 70 
subdivision (3) of this subsection absent a valid warrant or 71 
subpoena issued by a court of competent jurisdiction; and 72 
     (5)  Stores, transmits, and protects from disclosure 73 
all biometric identifiers and biometric infor mation in a  74 
manner that is the same as or more protective than the 75 
manner in which the private entity stores, transmits, and 76 
protects other confidential and sensitive information. 77 
     3.  Every private entity collecting biometric 78 
identifiers shall pla ce a notice in a clearly visible 79 
location or if in a written agreement or contract, in 80 
clearly readable print, stating the following warning: 81 
WARNING 82   SB 448 	4 
This entity obtains biometric identifiers or 83 
biometric information and complies with the 84 
collection and retention requirements under 85 
Missouri law.  This entity shall not be liable 86 
for damages for the unauthorized or negligent 87 
disclosure of such identifiers or information.   88 
Information about this entity's collection and 89 
retention schedule is made avail able to the  90 
public. 91 
     4.  The provisions of this section shall not be 92 
construed to: 93 
     (1)  Impact the admission or discovery of biometric 94 
identifiers and biometric information in any action in any 95 
court, or before any tribunal, board, or agency; 96 
     (2)  Conflict with the provisions of section 334.097, 97 
the federal Health Insurance Portability and Accountability 98 
Act of 1996 (HIPAA), P.L. 104 -191, as amended, and any rules 99 
promulgated thereunder; 100 
     (3)  Conflict with the provisions of section s 324.1100  101 
to 324.1148 and any rules promulgated thereunder; 102 
     (4)  Apply in any manner to a financial institution or 103 
an affiliate of a financial institution that is subject to 104 
Title V of the federal Gramm -Leach-Bliley Act of 1999, P.L. 105 
106-102, and any rules promulgated thereunder; or 106 
     (5)  Create or increase the liability of a private 107 
entity and does not affect the availability of any other 108 
immunities from or defenses to liability established by law 109 
or available under common law to which a p rivate entity may  110 
be entitled. 111 
